Case of Palytoxin-Related Keratitis Described

This article originally appeared here.
Share this content:
Case of Palytoxin-Related Keratitis Described
Case of Palytoxin-Related Keratitis Described

FRIDAY, May 6, 2016 (HealthDay News) -- In a letter to the editor published online April 30 in Clinical and Experimental Ophthalmology, unilateral palytoxin-induced chemical keratitis is described after a coral expressed its toxin into the patient's eye.

Nadia L. Chaudhry, from the Manchester Royal Eye Hospital in the United Kingdom, and colleagues described the case of a 45-year-old Caucasian female coral farmer who presented one day after a coral (Palythoa sp) expressed a toxin directly into her left eye.

On examination, visual acuity in the affected eye was 6/5; eyelid swelling, conjunctival chemosis and injection, diffuse punctate epithelial erosions, and a circumferential marginal ulcer were seen on slit lamp examination. The researchers diagnosed the patient with unilateral chemical keratitis. Topical ofloxacin eye drops were prescribed six times per day, along with hourly preservative-free lubricants. The patient felt subjectively worse the next day and was started on prednisolone eye drops twice/day. The pain decreased three days later, but there was still a 360-degree circumferential marginal infiltrate. Prednisolone eye drops were increased to four times/day. The eye looked white and quiet with mild peripheral corneal scarring and persistent corneal vascularization four weeks later. Over three months the steroids were tapered; the clinical picture remained unchanged.

"This case draws attention to the danger of their toxins and we recommend the use of protective equipment (face mask, goggles, and gloves) whilst handling these coral," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

More U.S. Teens Are Vaping, but Use of Opioids, Alcohol Falling

More U.S. Teens Are Vaping, but Use of ...

About 37 percent of 12th graders said they had vaped within the previous 12 months

Type 2 Diabetes Risk Lower in Women With Active Migraine

Type 2 Diabetes Risk Lower in Women With ...

Prevalence of active migraine decreased linearly in the 24 years prior to diabetes diagnosis

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Buprenorphine-Naloxone Cost-Effective for Opioid Use Disorder

Treatment costs less than extended-release naltrexone without negative impact on outcomes

is free, fast, and customized just for you!




Already a member?

Sign In Now »